PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sphere of biopharmaceuticals, featuring promising improvements throughout several health-related and industrial purposes. With its structural similarity to Normally derived human serum albumin, OsrHSA provides a safer, additional trusted alternative for therapeut